Arrayit Corporation Logo

Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.  - Powerful Science for Life™

Corporate - Media & Press - Press Release

Arrayit shows explosive new accounts growth.

Sunnyvale, CA, February 16, 2004 – Arrayit released figures for new accounts growth in 2004, revealing the strongest growth in company history.  For the first 6 weeks of 2004, TeleChem added 100 new Life Sciences accounts, marking the shortest time to add 100 new accounts in the company’s 10-year history.  TeleChem’s ArrayIt® product line is used by more than 3,000 regular customers and is the most widely used brand name in the microarray industry.  Microarrays are small glass chips that contain DNA and protein molecules used for biological research and diagnostics.  The ArrayIt® product line is used in essentially every academic, biotechnology, industrial, and medical diagnostics organization in the world.  The company has traditionally added 8-10 new accounts per week, so the spike of 100 new accounts (16.7 per week) to begin the 2004 was surprising and signaled positive signs for the first quarter and beyond.

René Schena, CEO of Arrayit responded to the new accounts report in this way. "My husband gave me a nice Valentine’s Day gift this year, but receiving news of our accounts expansion on February 14th made me just as happy.  We have seen a few trends during the past quarter that help explain why we have added new accounts faster than in previous years.  First, we are beginning to see some consolidation in the microarray industry, and in this respect new users are adopting ArrayIt® products more quickly than in years past.  We have also had recent success defending infringement of our 946’ patent, which covers our microarray manufacturing technology including microarray spotting pins and printheads.  With a major infringer exiting the microarray industry, we have seen an increase in the sale of our patented technology from both a new and current accounts perspective.  As we continue to successfully defend our patented products against other infringers, we expect to see continued growth of new accounts for our patented and proprietary ArrayIt® products.  We have also initiated expedited sales and customer support programs to service our expanding customer base, giving customers quality, price and service.  The three factors taken together help explain how we have been able to add 100 new accounts in an improving but challenging economy.  As always, I have to tip my hat to a very talented staff for hitting the ground running in 2004.”

About Arrayit
TeleChem International is a privately owned high-tech company located in the heart of California’s Silicon Valley.  Our products and services are provided by three corporate divisions: ArrayIt® Life Sciences Division, Chemicals Division, and a Diagnostics Division. The ArrayIt® Life Sciences Division offers a complete microarray technology platform that empowers >10,000 laboratories to use microarrays for human genome exploration, basic research, drug discovery, and myriad life sciences applications.  Nearly every major research institution uses our patented microarray manufacturing technology (U.S. 6,101,946) and supporting products and services.  The Chemicals Division provides import and export services and government contract manufacturing in the area of industrial chemicals for plastics, fire control, water treatment, agriculture, industrial and institutional compounding, and green energy. The Diagnostics Division holds key patents in the United States (6,913,879), Singapore (94899), New Zealand (523560), and other countries for its revolutionary “multi-patient” genotyping technology, which allows as many as 100,000 patients to be tested on a single microarray. Arrayit Diagnostics enables genotyping and disease diagnostics by providing testing kits, services, and technology transfer opportunities for disease screening and testing organizations.

Media Contact
Arrayit Corporation
Telephone: 408-744-1331
Email: investorrelations@arrayit.com
Web: www.arrayit.com
 

 

Copyright 1993-2017 Arrayit Corporation. All rights reserved.